DOI: 10.4244/EIJV11SWA1

Welcome to the special PCR London Valves 2015 supplement: a new team and venue, the same exceptional content

Jean Fajadet, Michael Haude, Bernard Prendergast, Corrado Tamburino, Stephan Windecker; PCR London Valves Course Directors and Guest Editors

In the relatively young discipline of transcatheter therapies for valvular heart disease, one tradition has emerged – the annual PCR London Valves meeting, taking place for the first time this year in Berlin, Germany. An official course of the EAPCI, the PCR London Valves programme is designed to provide attendees with a global overview of this increasingly mainstream clinical activity and new innovations in the field, all concentrated into three days of live cases, educational programmes, presentations and debates. Since the earliest days of PCR London Valves, EuroIntervention, the official journal of the EAPCI, has produced a dedicated supplement to the regular edition of the journal. This acts as a complement to the Course itself, providing the participants with a publication that is a compendium and reference work of the current state of the art in valve treatment.

Patrick W. Serruys, Editor-in-Chief of EuroIntervention, has once again invited the PCR London Valve Course Directors to be Guest Editors for this supplement, ensuring that it mirrors the interests and direction of the Course itself. This year, the general theme of the meeting is “The evolution of percutaneous valve therapy from TAVI to mitral intervention”. We hope the following pages will illuminate many aspects of this topic.

The interventional approach has become the standard therapy for mitral stenosis and pulmonary valve disease and a recognised alternative to surgery in inoperable and high-risk patients with severe aortic stenosis. It is also emerging as a treatment option in mitral and tricuspid regurgitation. Rapid technological developments in the last decade and newly affirmed methods of team working and case selection have set the stage for a revolution in the management of valvular heart disease.

The Editors have put together a supplement that is a comprehensive review of the interventional approach to valvular heart disease as practised today. These articles, authored by some of the world’s most recognised specialists, address current controversies, unanswered questions, latest technological advances and underlying clinical data from pivotal randomised controlled trials and large-scale international registries.

Looking at the table of contents, we begin with general perspectives in valvular heart interventions, followed by dedicated sections focusing on mitral, aortic or tricuspid valve interventions, as well as a section looking at the issues of the design and durability of different devices. We have also created a special “Device Parade” offering brief summaries of the different devices currently or soon to be in use, each described by a specialist with clinical experience in their use. We hope you will find this section a valuable quick reference given the increasing array of devices now entering or available in the clinical market.

This supplement would not have been possible without the commitment of our colleagues worldwide. We wish to thank them –many of them gave their time at very short notice– for having freely shared their knowledge and expertise. Like the Heart Team itself, it is by working together that we can move forward in the care we offer our patients. PCR London Valves remains dedicated to the transmission of clinical and theoretical knowledge. This supplement is designed to be an essential part of that undertaking.

Volume 11 Supplement W
Sep 17, 2015
Volume 11 Supplement W
View full issue


Key metrics

Suggested by Cory
Trending articles
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.45

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
72.95

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
60.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
26

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved